139460-10-9

Usage

Uses

Used in Chemical Synthesis:
Tert-butyl 4-Mercaptopyridin-3-ylcarbamate is used as a reagent in various chemical synthesis processes for its unique properties, contributing to the formation of new compounds and materials.
Used in Industrial Applications:
In the industrial sector, tert-butyl 4-Mercaptopyridin-3-ylcarbamate is employed as a component in the production of certain materials and products, leveraging its chemical characteristics to enhance performance and functionality.
Used in Research and Development:
Tert-butyl 4-Mercaptopyridin-3-ylcarbamate is utilized in scientific research and development as a subject of study to explore its potential applications and effects in different fields, including pharmaceuticals and materials science. This ongoing exploration aims to uncover more about its capabilities and how it can be safely and effectively used.

Upstream product

• 56700-70-0 3-(tert-butoxycarbonylamino)pyridine 
• 462-08-8 pyridin-3-ylamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 273-75-6 thiazolo[4,5-c]pyridine 
• 94391-50-1 5-methyl-4,5,6,7-tetrahydrothiazolo[4,5-c]pyridine 

Relevant academic research and scientific papers

Facile methods for preparation of thiazolopyridine and tetrahydrothiazolopyridine derivatives

The improved routes to prepare tetrahydrothiazolo[5,4-c]-pyridine-2- carboxylic acid lithium salts (2 and 3) were developed. Route A is consisted of the improved preparation of thiazolopyridine intermediates, and Route B is applicable for a large scale synthesis of tetrahydrothiazolo[5,4-c]pyridine-2- carboxylic acid derivatives. The methods we developed may serve as facile means for preparing thiazolopyridine and tetrahydrothiazolopyridine derivatives.

FERROPORTIN INHIBITORS AND METHODS OF USE

The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.

COMPOUNDS FOR TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS

Described herein are compounds and compositions for treating drug resistant and persistent tuberculosis. Also described herein is a method of screening for identifiying biofilm formation inhibitors.

Novel methods to functionalize thiazolo[4,5-c]pyridines

Novel substituted thiazole[4,5-c]pyridines have been synthesized in good yields from unsubstituted thiazole[4,5-c]pyridine using direct C-H coupling reactions and N-oxide rearrangement chemistry.

β-lactam compounds and process for producing the same

Novel β-lactam compound of the formula [1]: wherein R1is lower alkyl or hydroxy-substituted lower alkyl, R2is H or lower alkyl, X is O or, S, R3is H, metal or protecting group, W is a 6- or 7-membered nitrogen-containing heterocycle optionally being substituted at carbon atoms. Said β-lactam compound shows excellent antibacterial activity against Gram-positive bacteria, particularly against methicillin-resistantStaphylococcus aureusand methicillin-resistant and coagulase-negativeStaphylococcus aureus.